Tune in to Hep C Benefit Concert!

Share this

July 12, 2011
Dear Colleagues:
allmanAs many of you have seen in the news, Merck has launched a new public awareness campaign called Tune In to Hep C  in partnership with the American Liver Foundation.  The campaign features rock and roll hall of famer Gregg Allman of The Allman Brothers Band who received a liver transplant after his liver had become damaged from chronic hepatitis C infection.  Allman has returned to performing and recording music, and now wants to help raise awareness of hepatitis C and encourage others to take action.  
The campaign is kicking off with a benefit concert at the famed Beacon Theatre in New York City on July 27th, the eve of World Hepatitis Day.  The Beacon Theatre has special meaning to Allman who has played there every year for the last 20 years with the exception of 2007 when he was too ill to play.
We are very pleased to announce that 50% of the proceeds from that concert will be provided to NVHR to use for education, screening and policy initiatives supporting viral hepatitis.  This is such wonderful news and we are very grateful for the opportunity to be a part of this historic event, which will surely have a profound impact on awareness of this important public health issue.
Please be advised that we do not know the amount of the proceeds we will be receiving, as ticket sales are still being tallied, but will keep you informed as soon as that information is available.  We will be establishing the Gregg Allman Educational Grant Fund and, we will provide guidance on how the funds will be distributed once we have more information to share.
This is an exciting day for NVHR, as we will be able to use these funds to further our mission and to help community organizations to do their great work!  Many thanks again for your continued efforts and we will be in touch soon with additional updates from the Tune In to Hep C benefit concert.